IPP Bureau
Lupin acquires five brands from Menarini
By IPP Bureau - September 23, 2023
Lupin has been exclusively marketing these brands in the Indian market since July 2021
Need for strengthening primary and secondary healthcare network at the urban level: Health Secretary
By IPP Bureau - September 23, 2023
The state of the healthcare services will improve substantially with the involvement and participation of ULBs
Merck and Eisai update on Two Phase 3 Trials Evaluating Keytruda plus Lenima for cell lung cancer
By IPP Bureau - September 23, 2023
The companies will work with investigators to share the results with the scientific community
Emmes appoints Peter Ronco as CEO
By IPP Bureau - September 23, 2023
Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri
Redcliffe Labs’ diagnostics deliver ~$400 million in economic savings for India
By IPP Bureau - September 23, 2023
Research released at UN General Assembly week shows tests predicting heart disease and diabetes are among lowest cost solutions for improving Indian health
Dishman Carbogen Amcis updates on inspection by EDQM and AIFA
By IPP Bureau - September 22, 2023
The company's Bavla site was successfully jointly inspected by the EDQM and Italian Medicines Agency (AIFA)
Glenmark Pharma to sell 75% stake in Glenmark Life Sciences to Nirma for Rs. 5,652 Cr
By IPP Bureau - September 22, 2023
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
Natural Biogenex performs inauguration at Tumkur unit
By IPP Bureau - September 22, 2023
This production block consists of chemical synthesis reactions and clean rooms areas to produce final API
Asia Healthcare Holdings takes majority stake in Asian Institute of Nephrology and Urology
By IPP Bureau - September 22, 2023
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
Torque Pharmaceuticals launches campaign to celebrate World Pharmacist Day
By IPP Bureau - September 22, 2023
The campaign for the digital film is being amplified across various digital media platforms such as YouTube, Facebook, Instagram, Twitter, and LinkedIn
Biocon Biologics receives European Commission approval for biosimilar of Aflibercept ‘Yesafili’
By IPP Bureau - September 21, 2023
The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway
Zydus receives final approval from the USFDA for Clindamycin Phosphate Gel USP, 1%
By IPP Bureau - September 21, 2023
Clindamycin Phosphate Gel is used to treat acne
USFDA conducts inspection at InvaGen manufacturing facility in Central Islip, NY, USA
By IPP Bureau - September 21, 2023
InvaGen has received 5 inspectional observations in Form 483
Venus Remedies gets marketing approval for gemcitabine and docetaxel in Serbia
By IPP Bureau - September 21, 2023
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
Parexel appoints Gwyn Bebb to lead oncology clinical development
By IPP Bureau - September 21, 2023
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
